337.37
-7.97
(-2.31%)
At close: April 8 at 4:00:01 PM EDT
333.80
-3.57
(-1.06%)
Pre-Market: 6:45:04 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
4,242,000
4,242,000
3,711,000
2,624,000
3,263,000
Investing Cash Flow
-3,000,000
-3,000,000
-962,000
-2,924,000
-859,000
Financing Cash Flow
-525,000
-525,000
-1,594,000
-749,000
-2,365,000
End Cash Position
3,652,000
3,652,000
2,971,000
1,844,000
2,944,000
Income Tax Paid Supplemental Data
989,000
989,000
693,000
505,000
622,000
Interest Paid Supplemental Data
396,000
396,000
356,000
324,000
325,000
Capital Expenditure
-755,000
-755,000
-575,000
-588,000
-525,000
Issuance of Debt
3,011,000
3,011,000
1,241,000
1,500,000
5,000
Repayment of Debt
-2,039,000
-2,039,000
-2,058,000
-653,000
-1,151,000
Free Cash Flow
3,487,000
3,487,000
3,136,000
2,036,000
2,738,000
12/31/2021 - 3/17/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSX Boston Scientific Corporation
90.64
-0.98%
MDT Medtronic plc
81.88
-1.53%
ABT Abbott Laboratories
123.95
-0.73%
ZBH Zimmer Biomet Holdings, Inc.
102.79
-1.96%
EW Edwards Lifesciences Corporation
67.07
-2.80%
DXCM DexCom, Inc.
60.69
-1.53%
SNN Smith & Nephew plc
24.97
-2.65%
PODD Insulet Corporation
247.04
-3.59%
STE STERIS plc
208.55
-1.98%
GMED Globus Medical, Inc.
68.64
-2.98%